Dako Collaborates with Bristol-Myers Squibb for Pharmacodiagnostics

Dako … has entered into a collaboration with Bristol-Myers Squibb Company to develop pharmacodiagnostic tests intended to identify patients more likely to benefit from treatment with certain investigational cancer drug candidates under development by Bristol-Myers Squibb.
Fox Business